Erythropoietin Protects Neurons from Apoptosis Via Activating PI3K/AKT and Inhibiting Erk1/2 Signaling Pathway

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2019 Mar 14

PMID 30863710

Citations 13

Authors

Wei Si

Jianyi Wang

Mei Li

Hao Qu

Ran Gu

Rui Liu

Lu Wang

Shirong Li

Xiao Hu

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to explore the neuroprotective effect and the underlying mechanism of erythropoietin (EPO) on the cortical neuronal cells insulted with oxygen and glucose deprivation (OGD). Different concentrations of EPO were used to determine the anti-apoptosis effect of EPO. In addition, PI3K inhibitor LY294002 and ERK1/2 inhibitor U0126 were added to explore the underlying mechanism of EPO. Cell apoptosis rate was measured by flow cytometry. The protein expression of Bax, Bcl-2, cleaved caspase-3, AKT, p-AKT, Erk1/2 and p-Erk1/2 wasmeasured by Western blot. Our results showed that EPO alleviates OGD-induced cell apoptosis in a dose-dependent manner; the neuroprotective effect of EPO was further confirmed by the fact that EPO treatment reversed the protein expression of cleaved caspase-3, as well as the Bcl-2/Bax ratio as compared with the OGD treatment. In the mechanism part, our results demonstrated that OGD and EPO nearly had no influence on the protein expression of AKT and Erk1/2 but altered the phosphorylation of them. Specifically, OGD decreased the expression of p-AKT and increased the expression of p-Erk1/2; while, EPO treatment reversed the expression of p-AKT and p-Erk1/2 as compared with OGD treatment. Interestingly, LY294002 decreased the expression of p-AKT and attenuated the neuroprotective effect of EPO; while, U0126 decreased the expression of p-Erk1/2 and enhanced the neuroprotective effect of EPO. Our study demonstrated that EPO protects neurons against apoptosis induced by OGD, which is closely related with activation of PI3K/AKT and inactivation of Erk1/2 signaling pathway.

Citing Articles

Glaucoma: Current and New Therapeutic Approaches.

Lee H, Tsung T, Tsai Y, Chen Y, Lu D Biomedicines. 2024; 12(9).

PMID: 39335514 PMC: 11429057. DOI: 10.3390/biomedicines12092000.

A systematic review of the anti-inflammatory and anti-fibrotic potential of human umbilical cord mesenchymal stem cells-derived exosomes in experimental models of liver regeneration.

Puspita R, Jusuf A, Antarianto R, Sianipar I Mol Biol Rep. 2024; 51(1):999.

PMID: 39302506 DOI: 10.1007/s11033-024-09929-0.

Investigating the potential of mono-chalcone compounds in targeting breast cancer receptors through network pharmacology, molecular docking, molecular dynamics simulation, antiproliferative effects, and gene expressions.

Ismail N, Khairuddean M, Alidmat M, Abubakar S, Arsad H 3 Biotech. 2024; 14(6):151.

PMID: 38737798 PMC: 11087420. DOI: 10.1007/s13205-024-03991-y.

Impact of intraoperative dexmedetomidine on postoperative delirium and pro-inflammatory cytokine levels in elderly patients undergoing thoracolumbar compression fracture surgery: A prospective, randomized, placebo-controlled clinical trial.

Ye C, Shen J, Zhang C, Hu C Medicine (Baltimore). 2024; 103(18):e37931.

PMID: 38701286 PMC: 11062712. DOI: 10.1097/MD.0000000000037931.

Influences and mechanism of erythropoietin on the cognitive function of vascular dementia rats.

Tang Z, Li X, Yin N, Zhao M, Hu Q, Lv P Aging (Albany NY). 2023; 15(21):12264-12274.

PMID: 37934569 PMC: 10683607. DOI: 10.18632/aging.205178.

References

Xu G, Gong Z, Yu W, Gao L, He S, Qian Z . Increased expression ratio of Bcl-2/Bax is associated with crocin-mediated apoptosis in bovine aortic endothelial cells. Basic Clin Pharmacol Toxicol. 2007; 100(1):31-5. DOI: 10.1111/j.1742-7843.2007.00001.x. View

Salakou S, Kardamakis D, Tsamandas A, Zolota V, Apostolakis E, Tzelepi V . Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo. 2007; 21(1):123-32. View

Savoia C, Sisalli M, Di Renzo G, Annunziato L, Scorziello A . Rosuvastatin-induced neuroprotection in cortical neurons exposed to OGD/reoxygenation is due to nitric oxide inhibition and ERK1/2 pathway activation. Int J Physiol Pathophysiol Pharmacol. 2011; 3(1):57-64. PMC: 3068854. View

Souvenir R, Flores J, Ostrowski R, Manaenko A, Duris K, Tang J . Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia. Transl Stroke Res. 2013; 5(1):118-27. PMC: 3946340. DOI: 10.1007/s12975-013-0312-z. View

Jia Y, Mo S, Feng Q, Zhan M, Ouyang L, Chen J . EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease. J Mol Neurosci. 2014; 53(1):117-24. DOI: 10.1007/s12031-013-0208-0. View

Gong G, Yuan L, Cai L, Ran M, Zhang Y, Gong H . Tetramethylpyrazine suppresses transient oxygen-glucose deprivation-induced connexin32 expression and cell apoptosis via the ERK1/2 and p38 MAPK pathway in cultured hippocampal neurons. PLoS One. 2014; 9(9):e105944. PMC: 4169508. DOI: 10.1371/journal.pone.0105944. View

Grasso G, Alafaci C, Buemi M . Erythropoietin in Traumatic Brain Injury: An Answer Will Come Soon. World Neurosurg. 2015; 84(5):1491-2. DOI: 10.1016/j.wneu.2015.05.056. View

Wu Y, Mathur A, Chang T, McKinstry R, Mulkey S, Mayock D . High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial. Pediatrics. 2016; 137(6). DOI: 10.1542/peds.2016-0191. View

Ding J, Wang J, Li Q, Yu J, Ma C, Wang X . Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons. Mol Neurobiol. 2016; 54(7):5051-5060. DOI: 10.1007/s12035-016-0022-0. View

10.

Yan F, Zhang M, Meng Y, Li H, Yu L, Fu X . Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis. Brain Res. 2016; 1651:104-113. DOI: 10.1016/j.brainres.2016.09.024. View

11.

Li D, Li Y, Yuan H, Qu L, Wang P . The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism. 2017; 68:31-42. DOI: 10.1016/j.metabol.2016.12.003. View

12.

Yan X, Liu D, Zhang X, Liu D, Xu S, Chen G . Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway. Int J Mol Sci. 2017; 18(2). PMC: 5343924. DOI: 10.3390/ijms18020389. View

13.

Mikrogeorgiou A, Sato Y, Kondo T, Hattori T, Sugiyama Y, Ito M . Dedifferentiated Fat Cells as a Novel Source for Cell Therapy to Target Neonatal Hypoxic-Ischemic Encephalopathy. Dev Neurosci. 2017; 39(1-4):273-286. DOI: 10.1159/000455836. View

14.

Malla R, Asimi R, Teli M, Shaheen F, Bhat M . Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial. J Perinatol. 2017; 37(5):596-601. DOI: 10.1038/jp.2017.17. View

15.

Jeong J, Park J, Kim C, Lee S, Chung H, Kim W . Neuroprotective effects of erythropoietin against hypoxic injury via modulation of the mitogen-activated protein kinase pathway and apoptosis. Korean J Pediatr. 2017; 60(6):181-188. PMC: 5500386. DOI: 10.3345/kjp.2017.60.6.181. View

16.

Garg B, Sharma D, Bansal A . Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand. J Matern Fetal Neonatal Med. 2017; 31(23):3214-3224. DOI: 10.1080/14767058.2017.1366982. View

17.

Yoo S, Cho B, Lee D, Son G, Lee Y, Han H . The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage. Cell Death Dis. 2017; 8(8):e3003. PMC: 5596568. DOI: 10.1038/cddis.2017.381. View

18.

Biggar P, Kim G . Treatment of renal anemia: Erythropoiesis stimulating agents and beyond. Kidney Res Clin Pract. 2017; 36(3):209-223. PMC: 5592888. DOI: 10.23876/j.krcp.2017.36.3.209. View

19.

Chen T, Dai S, Li X, Luo P, Zhu J, Wang Y . Sirt1-Sirt3 axis regulates human blood-brain barrier permeability in response to ischemia. Redox Biol. 2017; 14:229-236. PMC: 5633840. DOI: 10.1016/j.redox.2017.09.016. View

20.

Castillo C, Zaror S, Gonzalez M, Hidalgo A, Burgos C, Cabezas O . Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress. Redox Biol. 2017; 14:285-294. PMC: 5975214. DOI: 10.1016/j.redox.2017.09.010. View